Nuclera is a biotechnology company that accelerates drug discovery by providing rapid, easy access to functional proteins through its benchtop eProtein Discovery™ System. The company combines cell-free expression systems, digital microfluidics, and multiplex protein screening to enable in-house protein expression, purification, and binding validation for biologics research.
Leadership & Board
Current Number of Employees115
Current LinkedIn Followers26,046
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$12M
Total Amount Raised$12M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$12M
Latest Funding Amount$12M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Nuclera had 115 employees as of September 7, 2026. The number of employees increased by 1 (0.88%) week-over-week.
115Latest Employee Count
1(0.88%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Nuclera had 26,046 followers as of September 7, 2026. The number of followers increased by 24 (0.09%) week-over-week.
26,046Latest Followers Count
24(0.09%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.